Brief: Bioarctic Partner Eisai Presents Leqembi Sales Simulation
25/05/2026 08:24
May 25 (Reuters) - BioArctic AB BIOAb.ST: BIOARCTIC'S PARTNER EISAI PRESENTS SALES SIMULATION OF POTENTIAL FUTURE SALES OF LEQEMBI AT ITS INVESTOR RELATIONS DAY ACCORDING TO EISAI'S SIMULATION, LEQEMBI SALES WILL REACH AROUND JPY 300 BILLION FOR COMPANY'S FY 2028 Source text: ID:nWkr81Jn4b Further company coverage: [BIOAb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on BioArctic AB
See all newsBrief: BioArctic And Lilly Sign Research, Collaboration Agreement
Brief: Bioarctic AB Declares Dividend Of Sek 2 Per Share With 1 June 2026 Record Date
Brief: Bioarctic Partner Eisai Presents Leqembi Sales Simulation
Sweden's BioArctic Q1 revenue drops sharply despite higher Leqembi royalties
Brief: BioArctic Q1 Operating Profit SEK 210.8 Million